Neuros Medical, Inc. Announces First Patient Feasibility Study Results

Published: Jan 18, 2011

CLEVELAND--(BUSINESS WIRE)--Neuros Medical, Inc., a medical device company announced today initial feasibility study results of their patented high frequency alternating current (HFAC) Nerve Block technology from their first patient. The study is a short-term, 30-day test per patient, focusing on chronic residual limb pain. Nearly one million patients suffer from chronic residual limb pain in the U.S.

Back to news